Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UB-421 in Asymptomatic HIV-1 Infected Adults
NCT01668043Phase 2Completed
- Sponsor
- United Biomedical, Inc.
- Start
- Sep 2012
- Primary completion
- Mar 2014
- Modality
- IgG Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of semzuvolimab in human immunodeficiency virus type 1 infection (HIV-1), sponsored by United Biomedical, Inc.. Started Sep 2012; status: completed.
02
Drugs
semzuvolimab
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01668043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01668043.